English
French
Indonesian
Korean
Malay799-P: Gender Differences in Diabetes Distress Comparing Dapagliflozin plus Saxagliptin to Glimepiride When Added to Metformin in Poorly Controlled Type 2 Diabetes
MARCIA A. TESTA and DONALD C. SIMONSON, Boston, MA Gender Differences in Diabetes Distress Comparing Dapagliflozin plus Saxagliptin to Glimepiride When Added to Metformin in Poorly Controlled Type 2 Diabetes Author Block: MARCIA A. TESTA,.
810-P: Patient-reported outcomes in T2D patients inadequately controlled by metformin are more favorable for dapagliflozin plus saxagliptin vs. insulin glargine.
MARCIA A. TESTA, DONALD C. SIMONSON, ELLA EKHOLM, MAXWELL SU, EVA K. JOHNSSON, Boston, MA, Mölndal, Sweden Patient-Reported Outcomes in T2D Patients Inadequately Controlled by Metformin Are More Favorable.
1520-P: Impact of Patient-Centered Factors on Comparative Effectiveness of Initial Therapies in Treatment-Naïve T2D
MARCIA A. TESTA, ALEXANDER TURCHIN, MAXWELL SU, DONALD C. SIMONSON, Boston, MA Impact of Patient-Centered Factors on Comparative Effectiveness of Initial Therapies in Treatment-Naïve T2D Author Block: MARCIA A..
941-P: Continuous Glucose Monitoring (CGM) Provides Enhanced Sensitivity Compared with Self-Monitored Blood Glucose (SMBG) for Detecting Hypoglycemia during T2D Clinical Trials.
MARCIA A. TESTA, SERGIO SALDIVAR-SALAZAR, MAXWELL SU, JOHANNA F. HAYES, DONALD C. SIMONSON, Boston, MA, Wellesley Hills, MA Continuous Glucose Monitoring (CGM) Provides Enhanced Sensitivity Compared with Self-Monitored Blood.
905-P: Continuous Glucose Monitoring Glycemic Variability Profiles Are More Favorable for Dapagliflozin plus Saxagliptin Compared with Insulin Glargine in Type 2 Diabetes.
DONALD C. SIMONSON, TINA VILSBØLL, ELLA EKHOLM, EVA K. JOHNSSON, MARCIA A. TESTA, SERGE JABBOUR, MARCUS LIND, Boston, MA, Copenhagen, Denmark, Mölndal, Sweden, Philadelphia, PA, Gothenburg, Sweden Continuous Glucose.
386-OR — 2017 Oral Presentation: A Social Media Learning Collaborative Approach to Competency-Based Training in Diabetes Diabetes Education – Presented Monday – June 12, 2017, SanDiego, CA
MARCIA A. TESTA, SERGIO SALDIVAR-SALAZAR, MAXWELL SU, LINDA G. MARC, DONALD C. SIMONSON, Boston, MA, Wellesley Hills, MA While there are many online courses explaining how clinical factors influence.
Annual Research Meeting of AcademyHealth, June 26 – 28, 2016
Annual Research Meeting of AcademyHealth, June 26 – 28, 2016 Oral Presentation: Effect of Medication Reconciliation on Emergency Department Visits and Hospitalizations in Patients with Diabetes. OLUKAYODE SOSINA, HUABING.
1387-P — 2016 ePoster Electronic Documentation of Lifestyle Counseling in Primary Care Is Associated with Lower Risk of Cardiovascular Events in Patients with Diabetes Health Care Delivery/Economics- Presented Sunday – Jun 12, 2016 12:00 PM – 2:00 PM
HUABING ZHANG,NAOSHI HOSOMURA, MARIA SHUBINA, DONALD C. SIMONSON, MARCIA A. TESTA, ALEXANDER TURCHIN Electronic Documentation of Lifestyle Counseling in Primary Care is Associated with Lower Risk of Cardiovascular Events.
1216-P — 2016 ePoster Effect of Medication Reconciliation on Emergency Department Visits and Hospitalizations in Patients with Diabetes Health Care Delivery/Economics- Presented Sunday – Jun 12, 2016 12:00 PM – 2:00 PM
OLUKAYODE SOSINA, HUABING ZHANG, MARIA SHUBINA,SONALI P. DESAI, DONALD C. SIMONSON, MARCIA A. TESTA Effect of Medication Reconciliation on Emergency Department Visits and Hospitalizations in Patients with Diabetes. ALEXANDER TURCHIN,.
1235-P — 2016 ePoster Patient-Centered Outcomes and Socio-Demographic Predictors of Diabetes Treatment Effectiveness Health Care Delivery Economics – Presented Sunday – Jun 12, 2016 12:00 PM – 2:00 PM
MARCIA A. TESTA, MAXWELL SU, ALEXANDER TURCHIN, DONALD C. SIMONSON, Boston, MA Patient-Centered Outcomes and Socio-Demographic Predictors of Diabetes Treatment Effectiveness. Author(s): MARCIA A. TESTA, MAXWELL SU, ALEXANDER TURCHIN, DONALD C..
823-P — 2016 ePoster: Impact of Subclinical Depression and Anxiety on Intensity and Frequency of Treatment-Related Side Effects and Symptoms Psychosocial, Behavioral Medicine – Presented Saturday – Jun 11, 2016 11:30 AM – 1:30 PM
MARCIA A. TESTA, LINDA G. MARC, ALEXANDER TURCHIN, DONALD C. SIMONSON, Boston, MA Impact of Subclinical Depression and Anxiety on Intensity and Frequency of Treatment-Related Side Effects and Symptoms..
770-P — 2015 ePoster: Health Education Internet Use by Persons with Diabetes in the U.S.
DONALD C. SIMONSON, LINDA G. MARC, MARCIA A. TESTA, Boston, MA Diabetes Education Presented on Monday, June 8, 2015 12:00 PM Author(s): DONALDC. SIMONSON, LINDA G. MARC, MARCIA A..
1330-P — 2015 ePoster Benchmarking T2DM Treatment Effectiveness in Clinical Practice
MARCIA A. TESTA, ALEXANDER TURCHIN, OLUKAYODE A. SOSINA, DONALD C. SIMONSON, Boston, MA Health Care Delivery/Economics Presented on Sunday, June 7, 2015 12:00 PM Author(s): MARCIAA. TESTA, ALEXANDER TURCHIN,.
211-OR – 2015 Oral Presentation Using Social Media Crowdsourced Data for Diabetes Patient-Centered Outcomes Research (PCOR) Psychosocial, Behavioral Medicine
MARCIA A. TESTA, SERGIO SALDIVAR-SALAZAR, ELENA SAVOIA, DONALD C. SIMONSON, Boston, MA Psychosocial, Behavioral Medicine Presented on Sunday, June 7, 2015 2:15 PM Author(s): MARCIA A. TESTA, SERGIO SALDIVAR-SALAZAR,.
839-P — 2014 CGM and SMBG Analytics Predict Hypoglycemic Risk and Symptoms during Intensive Insulin Titration
Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 15, 2014 12:00 PM Author(s): MARCIAA. TESTA, JASVINDER K. GILL, MAXWELL SU, LOUISE TRAYLOR, DONALD C. SIMONSON, Boston, MA, Bridgewater, NJ, Wellesley,MA The relationship.
1165-P — 2014 ePoster: Development of a Personalized, Patient-Centered Glycemic Control Benchmarking Tool for T2DM
MARCIA A. TESTA, DONALD C. SIMONSON, Boston, MA Presented on Sunday, June 15, 2014 12:00 PM Author(s): MARCIAA. TESTA, DONALD C. SIMONSON, Boston, MA Glycemic control treatment targets for.
681-P — 2013: Socioeconomic and Demographic Predictors of Internet and Social Media Use in Persons with Diabetes
Diabetes Education Presented on Monday, June 24, 2013 12:00 PM Author(s): MARCIAA. TESTA, DONALD C. SIMONSON, Boston, MA. Internet and social media tools to access and disseminate health information.
Impact of Weight Loss on Patient-Reported Outcomes in Obese Type 2 Diabetes
Session: New Findings from Controlled Behavioral Interventions Abstract Number: 1-OR Title: Impact of Weight Loss on Patient-Reported Outcomes in Obese Type 2 Diabetes Presentation Start: 6/21/2013 4:15:00 PM Presentation.
850-P — 2012: Assessing the Comparative Effectiveness (CE) of Basal-Bolus vs. Premix Insulin Using Continuous Glucose Monitoring (CGM) Summary Measures
Clinical Therapeutics/New Technology – Glucose Monitoring and Sensing Presented on Sunday, June 10, 2012 12:00 PM Author(s): DONALD C. SIMONSON, JASVINDER K. GILL, MAXWELL SU, LOUISE TRAYLOR, MARCIAA. TESTA,.
805-P — 2012: Improved Glycemic Control and Variability During Insulin Intensification Improve Patient-Centered Outcomes in Type 1 Diabetes
Psychosocial – Behavioral Medicine Presented on Saturday, June 9, 2012 11:30 AM Author(s): MARCIAA. TESTA, JASVINDER K. GILL, MAXWELL SU, LOUISE TRAYLOR, DONALD C. SIMONSON, Boston, MA, Bridgewater, NJ,.